These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6375472)

  • 1. [Effector mechanisms of IgA].
    Vaerman JP
    Ann Biol Clin (Paris); 1984; 42(1):61-70. PubMed ID: 6375472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW; Reinholdt J; Kilian M
    Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA receptors in health and disease.
    Wines BD; Hogarth PM
    Tissue Antigens; 2006 Aug; 68(2):103-14. PubMed ID: 16866880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens.
    Mestecky J; Czerkinsky C; Russell MW; Brown TA; Prince SJ; Moldoveanu Z; Jackson S; Michalek SM; McGhee JR
    Ann Allergy; 1987 Nov; 59(5 Pt 2):54-9. PubMed ID: 3318587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector mechanism of host resistance in murine giardiasis: specific IgG and IgA cell-mediated toxicity.
    Kaplan BS; Uni S; Aikawa M; Mahmoud AA
    J Immunol; 1985 Mar; 134(3):1975-81. PubMed ID: 3968437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocytes are unable to bind to or phagocytize IgA and IgG immune complexes formed with influenza virus in vitro.
    Scott CB; Ratcliffe DR; Cramer EB
    J Immunol; 1996 Jul; 157(1):351-9. PubMed ID: 8683137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.
    Kobayashi K; Fujiyama Y; Hagiwara K; Kondoh H
    Microbiol Immunol; 1987; 31(11):1097-106. PubMed ID: 3127662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants.
    Hostoffer RW; Krukovets I; Berger M
    J Immunol; 1993 May; 150(10):4532-40. PubMed ID: 8387096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.
    van der Steen L; Tuk CW; Bakema JE; Kooij G; Reijerkerk A; Vidarsson G; Bouma G; Kraal G; de Vries HE; Beelen RH; van Egmond M
    Gastroenterology; 2009 Dec; 137(6):2018-29.e1-3. PubMed ID: 19555692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of leucocyte chemokinesis and chemotaxis by human IgA.
    Kemp AS; Cripps AW; Brown S
    Clin Exp Immunol; 1980 May; 40(2):388-95. PubMed ID: 7438544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.
    Griffiss JM; Goroff DK
    J Immunol; 1983 Jun; 130(6):2882-5. PubMed ID: 6854021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of antigens and antibodies at mucosal surfaces.
    Lamm ME
    Annu Rev Microbiol; 1997; 51():311-40. PubMed ID: 9343353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.
    Renegar KB; Jackson GD; Mestecky J
    J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of analysis of immunoglobulin A levels in saliva].
    Bokor-Bratić M
    Med Pregl; 2000; 53(3-4):164-8. PubMed ID: 10965682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.
    Crottet P; Corthésy B
    J Immunol; 1998 Nov; 161(10):5445-53. PubMed ID: 9820520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.